Literature DB >> 20362292

Total lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not abdominal aortic aneurysms in apoE deficient mice.

Haruhito A Uchida1, Fjoralba Kristo, Debra L Rateri, Hong Lu, Richard Charnigo, Lisa A Cassis, Alan Daugherty.   

Abstract

OBJECTIVE: T and B lymphocytes are associated with atherosclerosis and aneurysms. Angiotensin II (AngII) infusion into hypercholesterolemic mice results in augmentation of atherosclerosis and abdominal aortic aneurysm (AAA) formation. In this study, we determined whether total lymphocyte deficiency reduced AngII-induced vascular diseases. METHODS AND
RESULTS: ApoE deficient (apoE -/-) mice were cross-bred with recombination activating gene-1 (Rag-1) deficient mice that lack mature T and B lymphocytes. Heterozygous littermates (Rag-1 +/-) have normal lymphocytic function and served as controls. Male and female apoE -/- mice that were either Rag-1 +/- or -/- were fed a normal laboratory diet and infused with either saline or AngII (1000ng/kg/min) subcutaneously via osmotic mini pump for 28 days. Total lymphocyte deficiency had no significant effect on body weight and systolic blood pressure prior to and during AngII infusion. However, it was associated with decreased serum cholesterol concentrations. AngII infusion increased atherosclerotic lesion area in Rag-1 +/- mice compared to saline (P=0.017 in males and P=0.004 in females). This effect was significantly blunted in Rag-1 -/- male (P=0.044), but not female mice. AngII-infusion promoted increased width of the abdominal aorta, with a greater effect in males. Despite the reduction in atherosclerosis in males, Rag-1 deficiency had no significant effect on AngII-induced aortic dilation in either gender.
CONCLUSION: T and B lymphocyte deficiency attenuates AngII-induced atherosclerosis in males but not AAA formation in apoE -/- mice. Copyright 2010 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20362292      PMCID: PMC2900415          DOI: 10.1016/j.atherosclerosis.2010.02.034

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN: 0021-9150            Impact factor:   5.162


  34 in total

1.  Quantification of atherosclerosis in mice.

Authors:  Alan Daugherty; Stewart C Whitman
Journal:  Methods Mol Biol       Date:  2003

2.  Angiotensin II-induced hypertension accelerates the development of atherosclerosis in apoE-deficient mice.

Authors:  D Weiss; J J Kools; W R Taylor
Journal:  Circulation       Date:  2001-01-23       Impact factor: 29.690

3.  Loss of atheroprotective effect of estradiol in immunodeficient mice.

Authors:  R Elhage; S Clamens; C Reardon-Alulis; G S Getz; C Fievet; A Maret; J F Arnal; F Bayard
Journal:  Endocrinology       Date:  2000-01       Impact factor: 4.736

4.  Effect of immune deficiency on lipoproteins and atherosclerosis in male apolipoprotein E-deficient mice.

Authors:  C A Reardon; L Blachowicz; T White; V Cabana; Y Wang; J Lukens; J Bluestone; G S Getz
Journal:  Arterioscler Thromb Vasc Biol       Date:  2001-06       Impact factor: 8.311

5.  Lymphocytes are important in early atherosclerosis.

Authors:  L Song; C Leung; C Schindler
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

6.  Angiotensin II increases urokinase-type plasminogen activator expression and induces aneurysm in the abdominal aorta of apolipoprotein E-deficient mice.

Authors:  Y X Wang; B Martin-McNulty; A D Freay; D A Sukovich; M Halks-Miller; W W Li; R Vergona; M E Sullivan; J Morser; W P Dole; G G Deng
Journal:  Am J Pathol       Date:  2001-10       Impact factor: 4.307

7.  Differential effects of doxycycline, a broad-spectrum matrix metalloproteinase inhibitor, on angiotensin II-induced atherosclerosis and abdominal aortic aneurysms.

Authors:  Michael W Manning; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-01-30       Impact factor: 8.311

8.  Aortic dissection precedes formation of aneurysms and atherosclerosis in angiotensin II-infused, apolipoprotein E-deficient mice.

Authors:  Kiran Saraff; Fjoralba Babamusta; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2003-07-10       Impact factor: 8.311

9.  Characterisation of T and B lymphocytes infiltrating abdominal aortic aneurysms.

Authors:  Esther Ocana; Juan-Carlos Bohórquez; José Pérez-Requena; José A Brieva; Carmen Rodríguez
Journal:  Atherosclerosis       Date:  2003-09       Impact factor: 5.162

10.  ANG II infusion promotes abdominal aortic aneurysms independent of increased blood pressure in hypercholesterolemic mice.

Authors:  Lisa A Cassis; Manisha Gupte; Sarah Thayer; Xuan Zhang; Richard Charnigo; Deborah A Howatt; Debra L Rateri; Alan Daugherty
Journal:  Am J Physiol Heart Circ Physiol       Date:  2009-02-27       Impact factor: 4.733

View more
  26 in total

Review 1.  Inflammatory cell phenotypes in AAAs: their role and potential as targets for therapy.

Authors:  Matthew A Dale; Melissa K Ruhlman; B Timothy Baxter
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-06-04       Impact factor: 8.311

2.  Role of T lymphocytes in angiotensin II-mediated microvascular thrombosis.

Authors:  Elena Y Senchenkova; Janice Russell; Elvira Kurmaeva; Dmitry Ostanin; D Neil Granger
Journal:  Hypertension       Date:  2011-09-12       Impact factor: 10.190

3.  A CD31-derived peptide prevents angiotensin II-induced atherosclerosis progression and aneurysm formation.

Authors:  Giulia Fornasa; Marc Clement; Emilie Groyer; Anh-Thu Gaston; Jamila Khallou-Laschet; Marion Morvan; Kevin Guedj; Srini V Kaveri; Alain Tedgui; Jean-Baptiste Michel; Antonino Nicoletti; Giuseppina Caligiuri
Journal:  Cardiovasc Res       Date:  2012-01-31       Impact factor: 10.787

4.  Activation of the vitamin D receptor selectively interferes with calcineurin-mediated inflammation: a clinical evaluation in the abdominal aortic aneurysm.

Authors:  Arend Jan Nieuwland; Vivianne Bc Kokje; Olivier H Koning; Jaap F Hamming; Karoly Szuhai; Frans H J Claas; Jan H N Lindeman
Journal:  Lab Invest       Date:  2016-05-30       Impact factor: 5.662

5.  MyD88 deficiency attenuates angiotensin II-induced abdominal aortic aneurysm formation independent of signaling through Toll-like receptors 2 and 4.

Authors:  A Phillip Owens; Debra L Rateri; Deborah A Howatt; Kathryn J Moore; Peter S Tobias; Linda K Curtiss; Hong Lu; Lisa A Cassis; Alan Daugherty
Journal:  Arterioscler Thromb Vasc Biol       Date:  2011-09-29       Impact factor: 8.311

Review 6.  Angiotensin II Signal Transduction: An Update on Mechanisms of Physiology and Pathophysiology.

Authors:  Steven J Forrester; George W Booz; Curt D Sigmund; Thomas M Coffman; Tatsuo Kawai; Victor Rizzo; Rosario Scalia; Satoru Eguchi
Journal:  Physiol Rev       Date:  2018-07-01       Impact factor: 37.312

7.  Loss of Resistance to Angiotensin II-Induced Hypertension in the Jackson Laboratory Recombination-Activating Gene Null Mouse on the C57BL/6J Background.

Authors:  Hong Ji; Amrita V Pai; Crystal A West; Xie Wu; Robert C Speth; Kathryn Sandberg
Journal:  Hypertension       Date:  2017-04-24       Impact factor: 10.190

8.  Interleukin-6-signal transducer and activator of transcription-3 signaling mediates aortic dissections induced by angiotensin II via the T-helper lymphocyte 17-interleukin 17 axis in C57BL/6 mice.

Authors:  Xiaoxi Ju; Talha Ijaz; Hong Sun; Sutapa Ray; Wanda Lejeune; Chang Lee; Adrian Recinos; Dong-Chuan Guo; Dianna M Milewicz; Ronald G Tilton; Allan R Brasier
Journal:  Arterioscler Thromb Vasc Biol       Date:  2013-05-16       Impact factor: 8.311

Review 9.  Novel mechanisms of abdominal aortic aneurysms.

Authors:  Hong Lu; Debra L Rateri; Dennis Bruemmer; Lisa A Cassis; Alan Daugherty
Journal:  Curr Atheroscler Rep       Date:  2012-10       Impact factor: 5.113

10.  Inhibition of Notch1 signaling reduces abdominal aortic aneurysm in mice by attenuating macrophage-mediated inflammation.

Authors:  Chetan P Hans; Sara N Koenig; Nianyuan Huang; Jeeyun Cheng; Susana Beceiro; Anuradha Guggilam; Helena Kuivaniemi; Santiago Partida-Sánchez; Vidu Garg
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-10-18       Impact factor: 8.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.